Compare Twist Bioscience Corp (TWST) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Clear Secure Inc — how do they compare? Twist Bioscience Corp trades at $157.11 (market cap $10.32B), while Clear Secure Inc trades at $43.54 (market cap $4.39B). The key difference: Twist Bioscience Corp is far larger — about 2.4× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.35% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Clear Secure Inc for 19 Days on average.
| TWST | YOU | |
|---|---|---|
Market Cap | $10.32B | $4.39B |
Volume | 5,894,998 | 1,899,845 |
Sector | Health | Technology |
52-Week High | $205.00 | $62.36 |
52-Week Low | $25.45 | $29.61 |
Typical Hold Time | 27 Days | 19 Days |
Enterprise Value | $10.24B | $3.54B |
Dividend Yield | — | 1.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Clear Secure (YOU) trades at $42.58, up 2.6% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with 27% revenue growth in Q2 2026, beating earnings estimates, and robust profitability margins. Recent partnership with CrowdStrike and corporate membership launch highlight growth initiatives. Analyst consensus is mixed with a $61.40 price target representing 44% upside potential.
The stock presents growth potential driven by expanding membership base and enterprise partnerships, but faces risks from competitive pressures and potential execution challenges. Current valuation at 28.77 P/E appears reasonable given growth trajectory, though technical indicators show some overbought conditions that may limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
